Minocycline Topical and Iron: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Minocycline Topical
Iron
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced efficacy of minocycline
Interaction Deep Dive
Coadministration of minocycline (tetracycline) and iron may impair the absorption of tetracyclines by iron-containing preparations1.
Why it happens (mechanism)
Reduced tetracycline absorption
Literature reports
6 reports — tap to read
a) Impaired gastrointestinal absorption of tetracycline by the concomitant administration of oral ferrous sulfate is well known. Ferrous sulfate has also been shown to interfere with the absorption of the tetracycline analogues, oxytetracycline, methacycline, and doxycycline 32.
b) Ferrous sulfate has been shown to significantly decrease the absorption of oxytetracycline. The administration of ferrous sulfate 250 mg with oral oxytetracycline 500 mg as a single dose significantly decreased oxytetracycline serum concentrations. The serum levels with oxytetracycline alone were 2.3 mcg/mL compared to a maximum of 1 microgram/mL with the combination 3.
c) Since this interaction may lead to serum levels of the antibiotic which are below the minimum inhibitory concentration, the effect of the time interval between tetracycline and iron administration was investigated in 38 healthy medical students. It was demonstrated that when tetracycline 500 mg, is ingested at 0.5, 1 or 2 hours after ferrous sulfate 600 mg, significant reductions in plasma levels of the antibiotic occur. Similar results were obtained when the tetracycline was taken 1 hour before the iron. However, the results of this investigation did indicate that when iron was administered 3 hours before or 2 hours after tetracycline, satisfactory antibiotic serum levels were achieved 4.
d) The exact mechanism by which iron impairs tetracycline absorption is not known. However, since tetracycline binds with various polyvalent metallic cations 567, two mechanisms have been proposed: 1) inhibited absorption may result from the formation of tetracycline-iron chelates or 2) when ferrous ion is present, the tetracyclines may bind to intestinal protein residues 8. Additionally, iron may bind doxycycline when it passes through the intestine via its enterohepatic circulation, therefore even parenteral doxycycline would be a problem with iron 9.
e) A reduction in half-life of IV doxycycline from 16.6 h to 11 h when given simultaneously with oral iron has been demonstrated 9. The same study indicated that 200 mg oral doxycycline given 3, 7, and 11 h prior to 80 mg of elemental iron (ferrous sulfate) still resulted in a 20% to 45% reduction in serum doxycycline. Therefore, a three hour interval between dosing may not be adequate when doxycycline and iron are prescribed simultaneously 10.
f) The concurrent administration of ferrous salts (40 mg or more of iron) and tetracycline derivatives can lead to decreased levels of the tetracycline (50% to 90%) and decreased absorption of the ferrous salt (up to 50%) 119123.
Common questions
Can I take Minocycline Topical and Iron together?
Reduced efficacy of minocycline Always confirm with your pharmacist or prescriber before making any change.
How serious is the Minocycline Topical and Iron interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Minocycline Topical or Iron need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (12)
- Product Information: EMROSI(R) oral extended-release capsules, minocycline HCl oral extended-release capsules. Journey Medical Corporation (per FDA), Scottsdale, AZ, 2024. DailyMed
- Neuvonen PJ: Interactions with the absorption of tetracyclines. Drugs 1976b; 11:45-54. DOI
- Neuvonen PJ, Gothoni G, Hackman R, et al: Interference of iron with the absorption of tetracycline in man. Br Med J 1970; 4:532-534.
- Gothoni G, Neuvonen PJ, Mattila M, et al: Iron-tetracycline interaction: effect of time interval between the drugs. Acta Med Scand 1972; 191:409. DOI
- Kohn KW: Mediation of divalent metal ions in the binding of tetracyclines to macromolecules. Nature 1971; 191:1156.
- Albert A & Rees CW: Avidity of the tetracyclines for the cations of metals. Nature 1956; 177:433. PubMed
- Albert A: Avidity of Terramycin(R) and Aureomycin(R) for metallic cations. Nature 1953; 172:201.
- Greenberger NJ: Absorption of tetracyclines: interference by iron. Ann Intern Med 1971; 74:792. PubMed
- Neuvonen PJ & Penttila O: Effect of oral ferrous sulphate on the half-life of doxycycline in man. Eur J Clin Pharmacol 1974; 7:361-363. DOI
- Cunha BA, Sibley CM, & Ristuccia AM: Doxycycline-review. Ther Drug Monit 1982; 4:115-135.
- Venho VM, Salonen RO, & Mattila MJ: Modification of the pharmacokinetics of doxycycline in man by ferrous sulfate or charcoal. Eur J Clin Pharmacol 1978; 14:277-280.
- Neuvonen PJ & Turakka H: Inhibitory effect of various iron salts on the absorption of tetracycline in man. Eur J Clin Pharmacol 1974; 7:357-360. PubMed
Keep reading about Minocycline Topical
Keep reading about Iron
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist